← All Arrowhead Pharmaceuticals, INC filings

Arrowhead Pharmaceuticals, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
ARWR
Arrowhead Pharmaceuticals, INC
SCHEDULE: Sarepta Fully Divests Arrowhead Pharmaceuticals Stake
Sarepta Therapeutics has fully divested its stake in Arrowhead Pharmaceuticals through a secondary sale and a share redemption tied to a milestone payment.
NASDAQ
ARWR
Arrowhead Pharmaceuticals, INC
SCHEDULE 13D: Sarepta Therapeutics Makes $325 Million Strategic Investment in Arrowhead Pharmaceuticals, Securing Board Seat and Collaboration Rights
Sarepta Therapeutics Investments, a subsidiary of Sarepta Therapeutics, has acquired a 9.5% stake in Arrowhead Pharmaceuticals for $325 million, formalizing a strategic collaboration and gaining board representation.